ClinicalTrials.Veeva

Menu
D

Duke University Health System | Duke Gastroenterology Clinic - Clinic 2

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ifinatamab
Lurbinectedin
Topotecan
Amrubicin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer (IDeate-Lung02)

This study was designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lun...

Enrolling
Small Cell Lung Cancer
Drug: Topotecan
Drug: Amrubicin

This is a Phase 1 study to evaluate the safety of CB-011 (the study treatment), an allogeneic chimeric antigen receptor (CAR-T) cell therapy that tar...

Enrolling
Relapsed/Refractory Multiple Myeloma
Biological: CB-011

This 2-part study intends to define the recommended Phase 2 dose of ifinatamab deruxtecan (I-DXd) based on the efficacy, safety, and pharmacokinetics...

Active, not recruiting
Extensive-stage Small-cell Lung Cancer
Drug: Ifinatamab Deruxtecan (I-DXd)

Trial sponsors

Daiichi Sankyo logo
C

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems